Pathological Tissue Formation and Degradation Biomarkers Correlate with Patient Reported Pain Outcomes: an Explorative Study

Overview

Journal Osteoarthr Cartil Open

Date 2023 Jun 21

PMID 37342785

Authors

Anne C Bay-Jensen

Mukundan Attur

Jonathan Samuels

Christian S Thudium

Steven B Abramson

Morten A Karsdal

Affiliations

Soon will be listed here.

Abstract

Background: The lack of disease modifying drugs in Osteoarthritis (OA) may be attributed to the difficulty in robust response based on patient-reported outcomes (PROs) linked to drug mechanism of action. Joint tissue turnover biomarkers are associated with disease progression. A subset of patients has elevated serum levels of CRP metabolite (CRPM). This explorative study investigates the associations between PROs and joint tissue turnover markers in patients with high or low CRPM.

Methods: Serum of 146 knee OA patients of the New York Inflammation cohort and 21 healthy donors were assessed for biomarkers of collagen degradation (C1M, C2M, C3M, C4M), formation (PRO-C1, PRO-C2, PRO-C3, PRO-C4), and CRPM. Mean (SD) age was 62.5 (10.1); BMI, 26.6 (3.6); 62% women; and, 67.6% had symptomatic OA. WOMAC pain, stiffness, function, and total were recorded at baseline and at two-year follow-up. Associations were adjusted for race, sex, age, BMI, and NSAID.

Results: There was no difference in markers between donors and patients. C2M correlated with the WOMAC scores in all CRPM groups. Significant correlations were observed between PROs and PRO-C4, C1M, and C3M in the CRPM group. The best predictive models for improvement were found for function and total with AUCs of 0.74 (p < 0.01) and 0.78 (p < 0.01). The best predictive models for worsening were found for function and total with AUCs of 0.84 (p < 0.01) and 0.80 (p < 0.05).

Conclusion: We hypothesize that collagen markers are prognostic tools for segregating patient populations in clinical trials.

References

Angst F, Aeschlimann A, Stucki G . Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the.... Arthritis Rheum. 2001; 45(4):384-91. DOI: 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0. View

Hochberg M, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P . Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial. JAMA. 2019; 322(14):1360-1370. PMC: 6784851. DOI: 10.1001/jama.2019.14735. View

Felson D, Niu J, Sack B, Aliabadi P, McCullough C, Nevitt M . Progression of osteoarthritis as a state of inertia. Ann Rheum Dis. 2012; 72(6):924-9. PMC: 5310527. DOI: 10.1136/annrheumdis-2012-201575. View

Heinegard D, Saxne T . The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):50-6. DOI: 10.1038/nrrheum.2010.198. View

Lees S, Golub S, Last K, Zeng W, Jackson D, Sutton P . Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. Arthritis Rheumatol. 2015; 67(5):1240-9. DOI: 10.1002/art.39063. View

Karsdal M, Manon-Jensen T, Genovese F, Kristensen J, Nielsen M, Sand J . Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2015; 308(10):G807-30. PMC: 4437019. DOI: 10.1152/ajpgi.00447.2014. View

Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C . Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective.... Arthritis Care Res (Hoboken). 2012; 64(11):1699-707. DOI: 10.1002/acr.21747. View

Bay-Jensen A, Manginelli A, Karsdal M, Luo Y, He Y, Michaelis M . Low levels of type II collagen formation (PRO-C2) are associated with response to sprifermin: a pre-defined, exploratory biomarker analysis from the FORWARD study. Osteoarthritis Cartilage. 2021; 30(1):92-99. DOI: 10.1016/j.joca.2021.10.008. View

Mak K, Mei R . Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease. Anat Rec (Hoboken). 2017; 300(8):1371-1390. DOI: 10.1002/ar.23567. View

10.

Siebuhr A, Petersen K, Arendt-Nielsen L, Egsgaard L, Eskehave T, Christiansen C . Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthritis Cartilage. 2013; 22(1):44-50. DOI: 10.1016/j.joca.2013.10.020. View

11.

Doganay Erdogan B, Leung Y, Pohl C, Tennant A, Conaghan P . Minimal Clinically Important Difference as Applied in Rheumatology: An OMERACT Rasch Working Group Systematic Review and Critique. J Rheumatol. 2015; 43(1):194-202. DOI: 10.3899/jrheum.141150. View

12.

Henriksen K, Leeming D, Christiansen C, Karsdal M . Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options. Womens Health (Lond). 2011; 7(6):689-98. DOI: 10.2217/whe.11.74. View

13.

Luo Y, Samuels J, Krasnokutsky S, Byrjalsen I, Kraus V, He Y . A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis. J Orthop Traumatol. 2021; 22(1):10. PMC: 7943687. DOI: 10.1186/s10195-021-00572-0. View

14.

Kehlet S, Willumsen N, Armbrecht G, Dietzel R, Brix S, Henriksen K . Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix. PLoS One. 2018; 13(3):e0194458. PMC: 5875766. DOI: 10.1371/journal.pone.0194458. View

15.

Attur M, Statnikov A, Samuels J, Li Z, Alekseyenko A, Greenberg J . Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. Osteoarthritis Cartilage. 2015; 23(11):1915-24. PMC: 4630783. DOI: 10.1016/j.joca.2015.08.006. View

16.

Sharma N, Drobinski P, Kayed A, Chen Z, Kjelgaard-Petersen C, Gantzel T . Inflammation and joint destruction may be linked to the generation of cartilage metabolites of ADAMTS-5 through activation of toll-like receptors. Osteoarthritis Cartilage. 2019; 28(5):658-668. DOI: 10.1016/j.joca.2019.11.002. View

17.

Wang S, Abramson S, Attur M, Karsdal M, Preston R, Lozada C . Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study. Osteoarthritis Cartilage. 2017; 25(12):1952-1961. DOI: 10.1016/j.joca.2017.09.007. View

18.

Karsdal M, Henriksen K, Bay-Jensen A . Biochemical markers in osteoarthritis with lessons learned from osteoporosis. Clin Exp Rheumatol. 2019; 37 Suppl 120(5):73-87. View

19.

Bihlet A, Karsdal M, Sand J, Leeming D, Roberts M, White W . Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD. Respir Res. 2017; 18(1):22. PMC: 5248528. DOI: 10.1186/s12931-017-0509-x. View

20.

Husakova M, Bay-Jensen A, Forejtova S, Zegzulkova K, Tomcik M, Gregova M . Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis. Sci Rep. 2019; 9(1):11218. PMC: 6677742. DOI: 10.1038/s41598-019-47502-z. View